Inflammatory Heart Disease Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: I495496C228EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Inflammatory Heart Disease in Global, including the following market information:

Global Inflammatory Heart Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Inflammatory Heart Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Atherosclerosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Inflammatory Heart Disease include Abbott, Johnson & Johnson, Roche, Novartis, Pfizer, AstraZeneca, Merck, GSK and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inflammatory Heart Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inflammatory Heart Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Inflammatory Heart Disease Market Segment Percentages, by Type, 2021 (%)

• Atherosclerosis
• Myocarditis
• Pericarditis

Global Inflammatory Heart Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Inflammatory Heart Disease Market Segment Percentages, by Application, 2021 (%)

• Hospitals and Diagnostic Centers
• Ambulatory Services Centers

Global Inflammatory Heart Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Inflammatory Heart Disease Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Inflammatory Heart Disease revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Inflammatory Heart Disease revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Johnson & Johnson
• Roche
• Novartis
• Pfizer
• AstraZeneca
• Merck
• GSK
• Bristol-Myers Squibb
• Eli Lilly
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Inflammatory Heart Disease Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Inflammatory Heart Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INFLAMMATORY HEART DISEASE OVERALL MARKET SIZE

2.1 Global Inflammatory Heart Disease Market Size: 2021 VS 2028
2.2 Global Inflammatory Heart Disease Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Inflammatory Heart Disease Players in Global Market
3.2 Top Global Inflammatory Heart Disease Companies Ranked by Revenue
3.3 Global Inflammatory Heart Disease Revenue by Companies
3.4 Top 3 and Top 5 Inflammatory Heart Disease Companies in Global Market, by Revenue in 2021
3.5 Global Companies Inflammatory Heart Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inflammatory Heart Disease Players in Global Market
  3.6.1 List of Global Tier 1 Inflammatory Heart Disease Companies
  3.6.2 List of Global Tier 2 and Tier 3 Inflammatory Heart Disease Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Inflammatory Heart Disease Market Size Markets, 2021 & 2028
  4.1.2 Atherosclerosis
  4.1.3 Myocarditis
  4.1.4 Pericarditis
4.2 By Type - Global Inflammatory Heart Disease Revenue & Forecasts
  4.2.1 By Type - Global Inflammatory Heart Disease Revenue, 2017-2022
  4.2.2 By Type - Global Inflammatory Heart Disease Revenue, 2023-2028
  4.2.3 By Type - Global Inflammatory Heart Disease Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Inflammatory Heart Disease Market Size, 2021 & 2028
  5.1.2 Hospitals and Diagnostic Centers
  5.1.3 Ambulatory Services Centers
5.2 By Application - Global Inflammatory Heart Disease Revenue & Forecasts
  5.2.1 By Application - Global Inflammatory Heart Disease Revenue, 2017-2022
  5.2.2 By Application - Global Inflammatory Heart Disease Revenue, 2023-2028
  5.2.3 By Application - Global Inflammatory Heart Disease Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Inflammatory Heart Disease Market Size, 2021 & 2028
6.2 By Region - Global Inflammatory Heart Disease Revenue & Forecasts
  6.2.1 By Region - Global Inflammatory Heart Disease Revenue, 2017-2022
  6.2.2 By Region - Global Inflammatory Heart Disease Revenue, 2023-2028
  6.2.3 By Region - Global Inflammatory Heart Disease Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Inflammatory Heart Disease Revenue, 2017-2028
  6.3.2 US Inflammatory Heart Disease Market Size, 2017-2028
  6.3.3 Canada Inflammatory Heart Disease Market Size, 2017-2028
  6.3.4 Mexico Inflammatory Heart Disease Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Inflammatory Heart Disease Revenue, 2017-2028
  6.4.2 Germany Inflammatory Heart Disease Market Size, 2017-2028
  6.4.3 France Inflammatory Heart Disease Market Size, 2017-2028
  6.4.4 U.K. Inflammatory Heart Disease Market Size, 2017-2028
  6.4.5 Italy Inflammatory Heart Disease Market Size, 2017-2028
  6.4.6 Russia Inflammatory Heart Disease Market Size, 2017-2028
  6.4.7 Nordic Countries Inflammatory Heart Disease Market Size, 2017-2028
  6.4.8 Benelux Inflammatory Heart Disease Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Inflammatory Heart Disease Revenue, 2017-2028
  6.5.2 China Inflammatory Heart Disease Market Size, 2017-2028
  6.5.3 Japan Inflammatory Heart Disease Market Size, 2017-2028
  6.5.4 South Korea Inflammatory Heart Disease Market Size, 2017-2028
  6.5.5 Southeast Asia Inflammatory Heart Disease Market Size, 2017-2028
  6.5.6 India Inflammatory Heart Disease Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Inflammatory Heart Disease Revenue, 2017-2028
  6.6.2 Brazil Inflammatory Heart Disease Market Size, 2017-2028
  6.6.3 Argentina Inflammatory Heart Disease Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Inflammatory Heart Disease Revenue, 2017-2028
  6.7.2 Turkey Inflammatory Heart Disease Market Size, 2017-2028
  6.7.3 Israel Inflammatory Heart Disease Market Size, 2017-2028
  6.7.4 Saudi Arabia Inflammatory Heart Disease Market Size, 2017-2028
  6.7.5 UAE Inflammatory Heart Disease Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Inflammatory Heart Disease Major Product Offerings
  7.1.4 Abbott Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Inflammatory Heart Disease Major Product Offerings
  7.2.4 Johnson & Johnson Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Inflammatory Heart Disease Major Product Offerings
  7.3.4 Roche Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.3.5 Roche Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Inflammatory Heart Disease Major Product Offerings
  7.4.4 Novartis Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Inflammatory Heart Disease Major Product Offerings
  7.5.4 Pfizer Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Inflammatory Heart Disease Major Product Offerings
  7.6.4 AstraZeneca Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Inflammatory Heart Disease Major Product Offerings
  7.7.4 Merck Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 GSK
  7.8.1 GSK Corporate Summary
  7.8.2 GSK Business Overview
  7.8.3 GSK Inflammatory Heart Disease Major Product Offerings
  7.8.4 GSK Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.8.5 GSK Key News
7.9 Bristol-Myers Squibb
  7.9.1 Bristol-Myers Squibb Corporate Summary
  7.9.2 Bristol-Myers Squibb Business Overview
  7.9.3 Bristol-Myers Squibb Inflammatory Heart Disease Major Product Offerings
  7.9.4 Bristol-Myers Squibb Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.9.5 Bristol-Myers Squibb Key News
7.10 Eli Lilly
  7.10.1 Eli Lilly Corporate Summary
  7.10.2 Eli Lilly Business Overview
  7.10.3 Eli Lilly Inflammatory Heart Disease Major Product Offerings
  7.10.4 Eli Lilly Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.10.5 Eli Lilly Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Business Overview
  7.11.3 Sanofi Inflammatory Heart Disease Major Product Offerings
  7.11.4 Sanofi Inflammatory Heart Disease Revenue in Global Market (2017-2022)
  7.11.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Inflammatory Heart Disease Market Opportunities & Trends in Global Market
Table 2. Inflammatory Heart Disease Market Drivers in Global Market
Table 3. Inflammatory Heart Disease Market Restraints in Global Market
Table 4. Key Players of Inflammatory Heart Disease in Global Market
Table 5. Top Inflammatory Heart Disease Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Inflammatory Heart Disease Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Inflammatory Heart Disease Revenue Share by Companies, 2017-2022
Table 8. Global Companies Inflammatory Heart Disease Product Type
Table 9. List of Global Tier 1 Inflammatory Heart Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inflammatory Heart Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Inflammatory Heart Disease Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Inflammatory Heart Disease Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Inflammatory Heart Disease Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Inflammatory Heart Disease Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Inflammatory Heart Disease Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Inflammatory Heart Disease Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Inflammatory Heart Disease Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Inflammatory Heart Disease Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Inflammatory Heart Disease Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Inflammatory Heart Disease Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Inflammatory Heart Disease Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Inflammatory Heart Disease Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Inflammatory Heart Disease Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Inflammatory Heart Disease Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Inflammatory Heart Disease Product Offerings
Table 32. Abbott Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Inflammatory Heart Disease Product Offerings
Table 35. Johnson & Johnson Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Inflammatory Heart Disease Product Offerings
Table 38. Roche Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Inflammatory Heart Disease Product Offerings
Table 41. Novartis Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Inflammatory Heart Disease Product Offerings
Table 44. Pfizer Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Inflammatory Heart Disease Product Offerings
Table 47. AstraZeneca Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Inflammatory Heart Disease Product Offerings
Table 50. Merck Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 51. GSK Corporate Summary
Table 52. GSK Inflammatory Heart Disease Product Offerings
Table 53. GSK Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Inflammatory Heart Disease Product Offerings
Table 56. Bristol-Myers Squibb Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 57. Eli Lilly Corporate Summary
Table 58. Eli Lilly Inflammatory Heart Disease Product Offerings
Table 59. Eli Lilly Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Inflammatory Heart Disease Product Offerings
Table 62. Sanofi Inflammatory Heart Disease Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Inflammatory Heart Disease Segment by Type in 2021
Figure 2. Inflammatory Heart Disease Segment by Application in 2021
Figure 3. Global Inflammatory Heart Disease Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Inflammatory Heart Disease Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Inflammatory Heart Disease Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inflammatory Heart Disease Revenue in 2021
Figure 8. By Type - Global Inflammatory Heart Disease Revenue Market Share, 2017-2028
Figure 9. By Application - Global Inflammatory Heart Disease Revenue Market Share, 2017-2028
Figure 10. By Region - Global Inflammatory Heart Disease Revenue Market Share, 2017-2028
Figure 11. By Country - North America Inflammatory Heart Disease Revenue Market Share, 2017-2028
Figure 12. US Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Inflammatory Heart Disease Revenue Market Share, 2017-2028
Figure 16. Germany Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 17. France Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Inflammatory Heart Disease Revenue Market Share, 2017-2028
Figure 24. China Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 28. India Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Inflammatory Heart Disease Revenue Market Share, 2017-2028
Figure 30. Brazil Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Inflammatory Heart Disease Revenue Market Share, 2017-2028
Figure 33. Turkey Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Inflammatory Heart Disease Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GSK Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli Lilly Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sanofi Inflammatory Heart Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)